Pharmacotherapy for anxiety disorders in children and adolescents |
| |
Authors: | Kodish Ian Rockhill Carol Ryan Sheryl Varley Chris |
| |
Affiliation: | a Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98105, USA b Department of Pediatrics, Yale University School of Medicine, PO Box 208064, New Haven, CT 06520-8064, USA |
| |
Abstract: | Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth. |
| |
Keywords: | Anxiety disorders Pharmacotherapy Selective serotonin reuptake inhibitor Children |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|